Myriad Genetics Inc (MYGN) - Financial and Strategic SWOT Analysis Review

1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Affymetrix, Inc.
  • Amgen Inc
  • Exact Sciences Corp
  • Hologic Inc
  • Nanosphere Inc
  • MORE
Myriad Genetics Inc (MYGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the Author to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that analyze genes, their expression levels and corresponding proteins to assess a person risk for developing disease later in life, accurately diagnose disease and determine a patient’s likelihood of responding to a particular drug. It also provides an array of pharmaceutical and clinical services. Myriad markets its products through its sales force in Europe and Canada and through distributor agreements in Latin American, Middle Eastern, Asian and African countries. The company has operations in the US, Spain, France, Switzerland, the UK, Canada, the Netherlands and Italy. Myriad is headquartered in Salt Lake City, Utah, the US.

Myriad Genetics Inc Key Recent Developments

Aug 21,2018: Myriad Genetics reports fiscal fourth-quarter and full-year 2018 financial results
May 28,2018: Myriad Genetics Signs Definitive Agreement to Acquire Counsyl
May 08,2018: Myriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results
May 04,2018: Myriad Genetics to Present Five Studies at the Seventh International Symposium on Hereditary Breast and Ovarian Cancer
Apr 23,2018: Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Myriad Genetics, Inc.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Affymetrix, Inc.
  • Amgen Inc
  • Exact Sciences Corp
  • Hologic Inc
  • Nanosphere Inc
  • MORE
Section 1 - About the Company
Myriad Genetics Inc - Key Facts
Myriad Genetics Inc - Key Employees
Myriad Genetics Inc - Key Employee Biographies
Myriad Genetics Inc - Major Products and Services
Myriad Genetics Inc - History
Myriad Genetics Inc - Company Statement
Myriad Genetics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis
Company Overview
Myriad Genetics Inc - Business Description
Business Segment: Diagnostics Segment
Overview
Performance
Business Segment: Other Segment
Overview
Performance
R&D Overview
Myriad Genetics Inc - Corporate Strategy
Myriad Genetics Inc - SWOT Analysis
SWOT Analysis - Overview
Myriad Genetics Inc - Strengths
Myriad Genetics Inc - Weaknesses
Myriad Genetics Inc - Opportunities
Myriad Genetics Inc - Threats
Myriad Genetics Inc - Key Competitors

Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances
Myriad Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Myriad Genetics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
Myriad Genetics Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments
Aug 21, 2018: Myriad Genetics reports fiscal fourth-quarter and full-year 2018 financial results
May 08, 2018: Myriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results
May 07, 2018: Genome Medical Enters Employer Market with Diverse Genetic Health Programs and Wave of New Partners
Apr 23, 2018: Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Myriad Genetics, Inc.
Apr 18, 2018: Counsyl to offer insight into streamlining genetic screening into OBGYN practice at the 2018 ACOG Annual Clinical and Scientific Meeting
Apr 04, 2018: Counsyl Highlights Importance of Patient Access to Genetic Testing at the 2018 ACMG Annual Clinical Genetics Meeting
Feb 06, 2018: Myriad Genetics Reports Fiscal Second-Quarter 2018 Financial Results
Jan 04, 2018: Counsyl Appoints Ann Rhoads to Board of Directors
Dec 14, 2017: Counsyl Appoints Pamela Sedmak to Board of Directors
Dec 04, 2017: Counsyl Appoints Noah Nasser as Chief Commercial Officer

Section 6 – Appendix
Methodology
Ratio Definitions
About
Contact Us
Disclaimer

List of Tables
Myriad Genetics Inc, Key Facts
Myriad Genetics Inc, Key Employees
Myriad Genetics Inc, Key Employee Biographies
Myriad Genetics Inc, Major Products and Services
Myriad Genetics Inc, History
Myriad Genetics Inc, Subsidiaries
Myriad Genetics Inc, Key Competitors
Myriad Genetics Inc, Ratios based on current share price
Myriad Genetics Inc, Annual Ratios
Myriad Genetics Inc, Annual Ratios (Cont...1)
Myriad Genetics Inc, Annual Ratios (Cont...2)
Myriad Genetics Inc, Interim Ratios
Myriad Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Myriad Genetics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
Myriad Genetics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Myriad Genetics Inc, Performance Chart (2014 - 2018)
Myriad Genetics Inc, Ratio Charts
Myriad Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Myriad Genetics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Siemens Healthcare GmbH
  • Nanosphere Inc
  • Hologic Inc
  • Exact Sciences Corp
  • Amgen Inc
  • Affymetrix, Inc.
  • Abbott Laboratories
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll